期刊文献+

血浆脑利钠肽水平与高血压病患者房颤的发生相关性研究 被引量:8

Study on the relation between plasma B~type natriuretic peptide and atrial fibrillation in patients with essential hypertension
在线阅读 下载PDF
导出
摘要 目的探讨在心脏收缩功能正常情况下,高血压病患者房颤的发生与血浆脑利钠肽(BNP)水平的相关性。方法146例心脏收缩功能正常的高血压病患者以发生房颤情况分为窦律、阵发性房颤和永久性房颤三组,进行血浆BNP水平、左房室大小的横断面调查。结果三组间年龄、血压水平、心脏超声检测左室射血分数、左室大小等能数差异无统计学意义(P>0·05);永久房颤组的左房内径大于实窦律组(P<0·05),血浆BNP水平高于窦律组(P<0·01),而阵发性房颤组血浆BNP虽高于窦律组,但差异无统计学意义(P>0·05)。结论心脏收缩功能正常的高血压病患者合并永久性房颤后,BNP水平明显升高,且与左房增大有关。BNP水平是否可为高血压病患者房颤的发生进行危险分层,及与房颤的相互影响机制有待进一步研究。 Objective To investigate the difference of brain natrivretic peptide (BNP) concentration in essential hypertension patients with or without atrial fibrillation (AF) .Methods 146 patients with essential hypertension and normal heart function patients were enrolled in this study. According to AF occurrence patients were divided into sinus rhythm, paroxysmal AF and persistent AF groups. Serum concentration of BNP and demographicvariables were analyzed. Results BNP(vs sinus rhythin group, P 〈 0.01 ) and left atrial diameter (vs sinus rhythin group, P 〈 0.05) in patients with persistent AF was significantly higher than in control group.Though also higher but with no significant difference in BNP and left atrial dianaeter in the paroxysmal AF group than in the control group. Conclusion The BNP plasma levels and left atrial dianaeter increase, and may be used to reflect the risk of AF occurrence in essential hypertension patients.
出处 《广西医学》 CAS 2006年第9期1346-1347,共2页 Guangxi Medical Journal
基金 广西科学基金项目(桂科青0229037)
关键词 原发性高血压 脑利钠肽 心房颤动 Essential hypertension Brain natriuretic pepfide Atrial fibrillation
  • 相关文献

参考文献10

  • 1Anan F,Takahashi N,Ooie T,et al.Role of insulin resistance in nondipper essential hypertensive[J].Hhypertens Res,2003,26(6):669~676.
  • 2林雪,陈连凤,朱文玲,方理刚,郭丽琳,杨伟.血浆脑钠素水平评价左心室收缩功能不全的意义[J].临床心血管病杂志,2004,20(3):155-157. 被引量:5
  • 3Inoue S,Murakami Y,Sano K,et al.Atrium as a source of brain natriuretic poly peptide inpatients with atrialfibrillation[J].J Card Fail,2000,6 (2):92~96.
  • 4Tsuchidak AK,Tanabe K.Influence of paroxysmal atrial fibrillation attack on brain natriuretic peptide secretion[J].J Cardiol,2004,44(1):11~12.
  • 5Rossi A,Enriquez-sarano M,Burnett JC,et al.Natriuretic peptide levels in atrial fibrillation:a prospective hormonal and Doppler echocardiographic study[J].J Am Coil Cardiol,2000,35(5):1 256~ 1 262.
  • 6陈柯萍,陈新.心房颤动的命名和分类[J].中华心律失常学杂志,2003,7(4):253-254. 被引量:14
  • 7Cowie MR,Mendez GF.BNP and congestive heart failure[J].Curr Probl Cardiol,2003,28(4):264 ~ 311.
  • 8Tsutamoto T,Wada A,Maeda K,et al.Attenuation of compensation of endogenous cardiac natriuretic peptide system in chronic heart failure:prognostic role of plasma brain natriuretic peptide concentration inpatients with chronic symptomatic left ventricular dysfunction[J].Circulation,1997,96(2):509~516.
  • 9Benjamin J,Wokf PA,d' Agostino RB,et al.Impact of atrial fibrillation on the risk of death:the Framingham Heart Study[J].Circulation,998,98(10):946~952.
  • 10Wang TJ,Larson MG,Levy D,et al.Plasma natriuretie peptide levels and the risk of cardiovascular events and death[J].N Engl J Med,2004,350(7):655~663.

二级参考文献15

  • 1[1]Remme W J, Swedberg K. European society of cardio-logy. Comprehensive guidelines for the diagnosis and treatment of chronic heart failure. Task force for the diagnosis and treatment of chronic heart failure of the european society of cardiology. Eur J Heart Fail, 2002,4:11-22.
  • 2[2]Leslie C W, Talmadge E K, Marvin I S,et al. A clinical, radiographic, and physiologic scoring system for the longitudinal assessment of patients with idiopathic pulmonary fibrosis. Am Rev Respir Dis, 1986,133:97-103.
  • 3[3]Venugopal J. Cardiac natriuretic peptide-hope or hype? J Clin Pharmacol Ther,2001,26:15-31.
  • 4[4]Clerico A, Lervasi G, Mariani G. Pathophysiologic relevance of measuring the plasma levels of cardiac natriuretic peptide hormaones in Humans.Horm Metab Res,1999,31:487-498.
  • 5[5]Hystad M E, Geiran O R, Attramadal H, et al. Regional cardiac expression and concentration of natriuretic peptides in patients with severe chronic heart failure. Acta Physiol Scand, 2001,171:395-403.
  • 6[6]Sagnella G A. Measurement and significance of circulating natriuretic peptides in cardiovascular disease. Clin Sci, 1998, 95:519-529.
  • 7[7]Maisel A S, Koon J, Krishnaswamy P,et al. Utility of B-natriuretic peptide as a rapid, point-of-care test for screening patients undergoing echocardiography to determine left vontricular dysfunction. Am Hear J, 2001,141:367-374.
  • 8Levy S, Maarek M, Coumel P, et al. Characterization of different subsets of atrial fibrillation in general practice in France, the ALFA Study. Circulation, 1999, 99: 3028-3035.
  • 9Wells JL, Karp RB, Kouchoukos NT, et al. Characterization of atrial fibrillation in man: studies following open heart surgery.PACE, 1978, 1: 426-438.
  • 10Koning KT, Kirchoff CJ, Smeets JR, et al. High-density mapping of electrically induced atrial fibrilation in humans. Circulation, 1994, 89: 1665-1680.

共引文献17

同被引文献59

引证文献8

二级引证文献36

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部